Table 5 Relationships among serum CA-125 level and clinicopathological parameters in ovarian cancer patients
CA-125 level median (range) | p | |
|---|---|---|
Age | ||
≤ 50 | 478 (58–1325) | 0.38 |
> 50 | 409 (19–780) | |
Residence | ||
Rural | 478 (58–1325) | 0.79 |
Urban | 525 (19–1325) | |
Family history | ||
− ve | 478 (58–564) | 0.7 |
+ ve | 489 (19–1325) | |
FIGO stage | ||
I/II | 478 (19–693) | 0.03* |
III/IV | 564 (58–1325) | |
Histological subtypes | ||
Serous | 489 (460–693) | 0.006* |
Mucinous | 564 (354–1325) | |
Endometrioid | 348 (19–780) | |
US | ||
Bilateral | 354 (55–693) | |
Multilocular | 453 (19–780) | 0.002* |
Solid | 564 (478–1325) | |